Clin2
NCT07511361Possibly a fitRecruiting

Tonlamarsen for high blood pressure after hospitalization

HypertensionAcute Severe HypertensionHypertensive EmergencyHypertensive Urgency

Part of Heart & circulation clinical trials.

This study tests an investigational medication (Tonlamarsen) for people who were recently hospitalized for a very severe high blood pressure episode and also have heart or kidney disease. It aims to see if the drug can help control blood pressure after discharge.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
140 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older and weigh at least 110 pounds (50 kg), with a BMI of 45 or less.
  • You were in the hospital within the last week for a very high blood pressure episode (top number 180 or higher, or bottom number 110 or higher), and you are now ready to go home (or have been home less than 7 days).
  • At your screening visit, your resting blood pressure (top number) is still high at 145 or higher.
  • You have a diagnosis of heart disease or kidney disease (like heart failure, coronary artery disease, or chronic kidney disease).
  • You have not had a stroke, heart attack, or heart procedure in the last 30 days, and you do not have significant liver disease.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07191899Recruiting· Phase 1
KN060 for treating high blood pressure

This trial tests a new medication called KN060 for people with high blood pressure (essential hypertension). It is for those who are not on medication or are on a stable single medication, and whose blood pressure is moderately high but not extremely high.

Shanghai, Shanghai Municipality
NCT07030101Not yet recruiting· Phase 3
Study of a new drug for uncontrolled high blood pressure

This study tests a new medication (TCA108) for people whose high blood pressure is not well controlled despite taking two blood pressure medicines. The goal is to see if TCA108 can safely lower blood pressure further.

NCT07465549Recruiting
A smarter way to manage hard-to-control high blood pressure

This trial uses a special blood pressure monitor (CART BP Pro) to help guide treatment for people whose blood pressure stays high despite standard care. You may qualify if your blood pressure is still too high even with medication.

Ansan
NCT06790927Not yet recruiting
Standardized blood pressure treatment study

This study tests a standard approach to lowering blood pressure in people whose blood pressure is not well controlled with current treatment. It may help find a more effective way to manage hypertension.

Shanghai, China
NCT04971720Recruiting· Phase 2/Phase 3
Personalized blood pressure timing therapy for some adults

This trial tests whether timing blood pressure medications (based on your natural daily body rhythms) can improve blood pressure control. It’s designed for adults with moderately high blood pressure and focuses on who may benefit from a more precise schedule.

Birmingham, Alabama
NCT07758634Recruiting· Phase 1/Phase 2
Study of an experimental treatment for high blood pressure

This trial tests a new treatment called CTX340 for high blood pressure that is hard to control even with multiple medications. The study aims to see if it is safe and effective.

Port Orange, Florida

Hear when a new High blood pressure trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.